ストックスクリーナーアプリを入手
5.62
3.69%
0.20
アフターアワーズ：
5.75
0.13
+2.31%
前日終値:
$5.42
開ける：
$5.52
24時間の取引高:
473.56K
Relative Volume:
0.77
時価総額：
$515.68M
収益：
$14.02M
当期純損益:
$-84.03M
株価収益率:
-3.8231
EPS:
-1.47
ネットキャッシュフロー:
$-125.54M
1週間 パフォーマンス:
-12.87%
1か月 パフォーマンス:
+8.08%
6か月 パフォーマンス:
-15.62%
1年 パフォーマンス:
+10.85%
1日の値動き範囲:
$5.445
$5.75
1週間の範囲:
$5.14
$6.72
52週間の値動き範囲:
$3.85
$8.75
Meiragtx Holdings Plc Stock (MGTX) Company Profile
名前
Meiragtx Holdings Plc
セクター
電話
646-860-7985
住所
450 EAST 29TH STREET, NEW YORK, NY
MGTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
5.62 | 515.68M | 14.02M | -84.03M | -125.54M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-31 | 再開されました | Chardan Capital Markets | Buy |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-09-15 | 再開されました | BofA Securities | Buy |
| 2019-09-03 | 開始されました | Piper Jaffray | Overweight |
| 2019-02-27 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-07-03 | 開始されました | Barclays | Overweight |
| 2018-07-03 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Meiragtx Holdings Plc (MGTX) 最新ニュース
Wells Fargo & Company MN Has $144,000 Stock Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMA - GuruFocus
MeiraGTx (MGTX) Gains RMAT Designation for Parkinson's Treatment - GuruFocus
FDA grants RMAT status to MeiraGTx’s Parkinson’s treatment By Investing.com - Investing.com South Africa
MeiraGTx (MGTX) Gains FDA RMAT Designation for Parkinson's Treat - GuruFocus
MeiraGTx gets FDA RMAT status for its Parkinson’s disease treatment - Seeking Alpha
MeiraGTx (MGTX) Gains FDA RMAT Designation for Parkinson's Treatment | MGTX Stock News - GuruFocus
MeiraGTx Holdings Receives FDA RMAT Designation for AAV-GAD - TipRanks
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson's Disease - The Manila Times
FDA grants RMAT status to MeiraGTx’s Parkinson’s treatment - Investing.com
MeiraGTx Holdings Receives RMAT Designation from FDA for AAV-GAD Gene Therapy in Parkinson's Disease - Nasdaq
Invesco Ltd. Increases Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings PLC expected to post a loss of 49 cents a shareEarnings Preview - TradingView
MeiraGTx Holdings plc's (NASDAQ:MGTX) Shift From Loss To Profit - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Bought by Geode Capital Management LLC - Defense World
Kadmon Announces Sale of 1.4 Million Shares of MeiraGTx Holdings plc - ACCESS Newswire
What is the investor’s view on MeiraGTx Holdings plc (MGTX)? - uspostnews.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by JPMorgan Chase & Co. - Defense World
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - ADVFN
MeiraGTx CFO Richard Giroux sells $144,000 in stock By Investing.com - Investing.com India
MeiraGTx CFO Richard Giroux sells $144,000 in stock - Investing.com
Parkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Russell Investments Group Ltd. Has $1.72 Million Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MGTX Stock Update: MeiraGTx Holdings plc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Corebridge Financial Inc. - Defense World
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 By Investing.com - Investing.com UK
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 - Investing.com
(MGTX) Trading Advice - news.stocktradersdaily.com
MeiraGTx Holdings Signs New Lease in New York - TipRanks
MeiraGTx Holdings secures new lease, terminates old sublease - Investing.com Australia
MeiraGTx Holdings secures new lease, terminates old sublease By Investing.com - Investing.com Canada
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Debt Sensibly? - simplywall.st
MeiraGTx Reports Strategic Advances and Financial Results - TipRanks
Charles Schwab Investment Management Inc. Buys 12,961 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Chardan Capital Forecasts MeiraGTx FY2026 Earnings - MarketBeat
Chardan Capital Comments on MeiraGTx FY2026 Earnings - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Position Increased by Bank of New York Mellon Corp - Defense World
Chardan Capital Forecasts MeiraGTx FY2025 Earnings - Defense World
MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo
Reviewing MeiraGTx (NASDAQ:MGTX) and CRISPR Therapeutics (NASDAQ:CRSP) - Defense World
MeiraGTx (NASDAQ:MGTX) Given New $13.00 Price Target at Royal Bank of Canada - Defense World
MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment - Insider Monkey
RBC Capital raises MeiraGTx stock price target to $13.00 By Investing.com - Investing.com Canada
RBC Capital raises MeiraGTx stock price target to $13.00 - Investing.com
Meiragtx Holdings Plc (MGTX) 財務データ
収益
当期純利益
現金流量
EPS
4.10%
大文字化:
|
ボリューム (24 時間):